Electronic Medical Record Alerts to Optimize Medical Therapy in Heart Failure and Reduced Ejection Fraction

Instituto Cardiovascular de Buenos Aires240 enrolled

Overview

OPTIMAL-HF is a pragmatic, cluster randomized, single-blind intervention trial that will be conducted at an outpatient clinic in Argentina. The trial will assess the effectiveness of an individualized-based alert system compared to usual care in improving GDMT optimization at 90 days in patients with HFrEF.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

240

Conditions

HFrEF - Heart Failure With Reduced Ejection Fraction

Interventions

EMR alertOTHER

EMR alert for medication optimization

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Patients Inclusion Criteria: * Eligible patients will include those with an EF ≤ 40% on their most recent echocardiogram, age \> 18, and an outpatient cardiology encounter during the study period. * Age 18 or over Exclusion Criteria: * under optimal medical treatment * palliative care, or undergoing hemodialysis will be excluded Cardiologist Inclusion criteria: Cardiologists from an outpatient clinic at a cardiovascular center in Buenos Aires will be selected for potential participation in the study. Exclusion criteria Cardiologists belonging to the heart failure service

Outcomes

Primary Outcomes

The primary efficacy endpoint will be the GDMT optimize score in HfrEF patients 90 days after randomization.

Time frame: 90 days

Central Contacts

Lucrecia Burgos, MD

CONTACT

47508700 lburgos@icba.com.ar

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.